Fluorine (19F) MRS and MRI in biomedicine. - Wikidata - awgldk - TriplyDB

Fluorine (19F) MRS and MRI in biomedicine.

Fluorine (19F) MRS and MRI in biomedicine.

http://www.wikidata.org/entity/Q34635770

about

Stem Cell Tracking with Nanoparticles for Regenerative Medicine Purposes: An Overview Advancing Cardiovascular, Neurovascular, and Renal Magnetic Resonance Imaging in Small Rodents Using Cryogenic Radiofrequency Coil Technology Advances in using MRI probes and sensors for in vivo cell tracking as applied to regenerative medicine Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approaches Pre- and postmortem imaging of transplanted cells.Review: magnetic resonance imaging techniques in ophthalmology.Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents Enlargement of cerebral ventricles as an early indicator of encephalomyelitis Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.Monitoring/Imaging and Regenerative Agents for Enhancing Tissue Engineering Characterization and Therapies Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy Fluorinated graphene oxide; a new multimodal material for biological applications.Fluorine NMR reporter for phosphate anions.LipoCEST and cellCEST imaging agents: opportunities and challenges.(19)F Magnetic Resonance Imaging Signals from Peptide Amphiphile Nanostructures Are Strongly Affected by Their Shape Self-Sorting and Coassembly of Fluorinated, Hydrogenated, and Hybrid Janus Dendrimers into Dendrimersomes.Novel fluorinated ligands for gold nanoparticle labelling with applications in 19F-MRI.(19)F spin-lattice relaxation of perfluoropolyethers: Dependence on temperature and magnetic field strength (7.0-14.1T)In vivo performance of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile acid transport Temporal accumulation and localization of isoflurane in the C57BL/6 mouse and assessment of its potential contamination in 19 F MRI with perfluoro-crown-ether-labeled cardiac progenitor cells at 9.4 Tesla.Enhancing magnetic resonance imaging with contrast agents for ultra-high field strengths In vivo tracking of human neural stem cells with 19F magnetic resonance imaging ¹⁹F NMR indicator displacement assay using a synthetic receptor with appended paramagnetic relaxation agent.Evaluation of lung recovery after static administration of three different perfluorocarbons in pigs.Synthesis and characterization of perfluoro-tert-butyl semifluorinated amphiphilic polymers and their potential application in hydrophobic drug delivery Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies Optimization of rapid acquisition with relaxation enhancement (RARE) pulse sequence parameters for ¹⁹F-MRI studies.Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease.Monitoring the Stability of Perfluorocarbon Nanoemulsions by Cryo-TEM Image Analysis and Dynamic Light Scattering Balanced UTE-SSFP for 19F MR imaging of complex spectra Probe-Specific Procedure to Estimate Sensitivity and Detection Limits for 19F Magnetic Resonance Imaging.Personalized nanomedicine advancements for stem cell tracking.Synthesis of Intrinsically Disordered Fluorinated Peptides for Modular Design of High-Signal 19 F MRI Agents.Accelerated fluorine-19 MRI cell tracking using compressed sensing.Quantitative "Hot Spot" Imaging of Transplanted Stem Cells using Superparamagnetic Tracers and Magnetic Particle Imaging (MPI).Nanoparticles and clinically applicable cell tracking.Using fluorine-containing amphiphilic random copolymers to manipulate the quantum yields of aggregation-induced emission fluorophores in aqueous solutions and the use of these polymers for fluorescent bioimaging.Visualizing brain inflammation with a shingled-leg radio-frequency head probe for 19F/1H MRI.Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile Acid transporter activity Microencapsulated cell tracking.

P2860

Q26770087-16A0B84B-9726-437F-85BC-26161370AC56 Q26776191-FE28B3F8-D22C-4383-9A76-9B851DBCF016 Q26863117-ADC7A35D-ECA1-4334-A709-E5D818A5416E Q26865120-CAA1CD9D-0711-4559-8DB4-2D839CBBC0B9 Q26995358-611295CF-8F6B-489A-9498-A5071525E0AE Q27005563-0C726152-B97D-49F5-B649-7CBD92871A17 Q27027613-CF47FDFC-17B3-4884-8238-AB43BF6B715E Q27308739-FADB85CD-E650-4E39-AB80-75ACC73F6F6E Q30354652-0584107E-B6BD-4BFC-B061-CD99B6680829 Q30362056-F727695F-51A9-4821-9013-CCC4984C6A61 Q30426880-857ABF6E-4E69-4644-B59B-5EAF4B5427D4 Q30428231-33CA1A09-53F6-4A13-8989-DFC0C8FC4491 Q30619970-2BDA1633-287D-4B1D-A147-54516C413C43 Q31039858-46579081-B424-49A8-9238-1299270F1BFF Q31115271-6BC5B8DB-D7DD-405B-A35E-376892DB3CE3 Q31125843-08154FA4-100E-4C6F-AEFF-390E63D1D92B Q31160391-5AA62B79-99F5-4DCE-AA9A-2DA1F63FEAA8 Q33561016-40582E9E-69AC-473C-A2F6-3A080714D244 Q33598772-6320CD7E-045A-45A8-98C2-DAED70B31BB9 Q33834305-6B6F9C92-C866-4346-A411-CCD1272B7858 Q34071930-9DE43E1C-E820-4840-A31A-4CF15911C8CD Q34117143-FB2AF885-97C4-43F0-8DD6-E49FECB271ED Q34171532-E3EEE36F-33E9-4F38-8B8E-0212598A5747 Q34256610-22EA2205-0561-41AD-9663-A828E38FEB1A Q34441150-C3449CC8-EACF-4A85-B559-4DC54EC9DCB2 Q35200156-EBF8E805-649A-4F89-A306-C1F932E3A1F9 Q35210872-ADDD4BC9-9678-4E89-8EC7-D78E4B37FEFE Q35298233-7564EDD5-7215-4A12-818A-9A5495367753 Q35670605-E7D5534C-5CE5-41BB-B15D-538080048BC7 Q35789062-69D4A45D-AE64-46CB-8626-4238DF1578D2 Q36160442-06262EC1-C6C4-4E0B-A0EE-6573A4DA9EEE Q36335838-8DC4FF91-0833-48AA-BEA1-D2E6FA162566 Q36362772-F557570B-380A-43AC-8A07-62F04DA4A12F Q36388974-A6453731-E3E2-48CC-AA5B-4E370E914CD6 Q36425011-47B38474-6BDB-43C3-8BAF-8D5F24DBEF55 Q36514508-988A60EE-5A7A-4895-B2E5-B601C62DDAB2 Q36590423-1C37ABAF-1106-4511-9209-CE84A13140D3 Q36612391-2DF2445B-E70D-4D5B-B76B-E6729995E629 Q36745592-F11D96F5-62F8-4266-83A7-938FC4AD21EE Q36847331-1A21CF56-E4B8-4DF1-81B6-B7888521D4DC

P2860

Fluorine (19F) MRS and MRI in biomedicine.

http://www.wikidata.org/entity/Q34635770

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Fluorine (19F) MRS and MRI in biomedicine.

@ast

Fluorine (19F) MRS and MRI in biomedicine.

@en

type

label

Fluorine (19F) MRS and MRI in biomedicine.

@ast

Fluorine (19F) MRS and MRI in biomedicine.

@en

prefLabel

Fluorine (19F) MRS and MRI in biomedicine.

@ast

Fluorine (19F) MRS and MRI in biomedicine.

@en

P1433

Q34635770-AC29A346-F301-4D09-B3D2-5CC1890A836A

P1476

Q34635770-0502B423-322E-4E18-80BA-A6A135C1C3A6

P2093

Q34635770-25764348-27B1-407C-8C54-E8A417CB1C46

Q34635770-597D07E1-F951-4138-BDA9-4C8F887551AB

Q34635770-DDD58D40-B376-4E9F-8C2F-A6B9F5DD075C

Q34635770-EC51769D-D9B9-425B-80F9-AFDA88B4E491

P2860

Q34635770-02F5824E-0AB4-4300-B9B5-AB75C5A6B393

Q34635770-08582D7D-EEF2-470D-A15A-6D1A678CCCB2

Q34635770-09422547-246A-4FB8-B7F9-1D0AC308D395

Q34635770-0B352EAF-4EEB-4B26-BE99-36B7C5B1FA6D

Q34635770-0BFF0403-7419-4515-814E-A28803C651CE

Q34635770-14BA23C7-03FC-498A-9601-7888D2EEB5C6

Q34635770-170AD782-6FA3-4ADA-9571-E09E330691B1

Q34635770-1ECB18FC-408D-4B65-A626-E55CA8053717

Q34635770-20545188-6FE8-423A-A7E1-C7F7F281CD99

Q34635770-2428C148-2C70-4EB3-A605-440608CE3977

P304

Q34635770-8F7842D2-CD86-433C-B0B0-61799EEFEE3D

P31

Q34635770-9B27D8A2-F6EB-4021-9938-E29C9FF4326F

P356

Q34635770-09FE99F2-86D2-4FCE-9393-5C0FCA8333C8

P433

Q34635770-3960D73C-C18E-45F1-A9F4-E4704D90CA50

P478

Q34635770-CFFA6093-BED1-4751-A5B0-9E6278448457

P577

Q34635770-500754DE-FABC-40B0-917C-28DEB23E891D

P5875

Q34635770-E990D543-AADA-4C09-AEB4-FAFF50D91DA2

P698

Q34635770-3BD6F913-3BB0-41F5-8E59-609172321157

P932

Q34635770-FD9B0B59-8DD3-46B4-9F8F-46F703492D3C

P356

P1433

NMR in Biomedicine

P1476

Fluorine (19F) MRS and MRI in biomedicine.

@en

P2093

Brad P Barnett

http://www.w3.org/2001/XMLSchema#string

Jeff W M Bulte

http://www.w3.org/2001/XMLSchema#string

Jesús Ruiz-Cabello

http://www.w3.org/2001/XMLSchema#string

Paul A Bottomley

http://www.w3.org/2001/XMLSchema#string

P2860

Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins, and cholesterol: A study of occupationally exposed men

Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions

An advanced expiratory circuit for the recovery of perfluorocarbon liquid from non-saturated perfluorocarbon vapour during partial liquid ventilation: an experimental model.

Fluorinated pyrimidines, a new class of tumour-inhibitory compounds

A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: A 19-F MRS study

Perfluorooctylbromide: a new contrast agent for CT, sonography, and MR imaging

MRI of lungs using partial liquid ventilation with water-in-perfluorocarbon emulsions.

Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery.

Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles.

Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON).

P304

114-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/NBM.1570

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46274488

http://www.w3.org/2001/XMLSchema#string

P698

20842758

http://www.w3.org/2001/XMLSchema#string

P932

3051284

http://www.w3.org/2001/XMLSchema#string